S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 81 to 114 of 114

Issue Date	Title / Author(s) / Citation	File
2015-11	The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388
2015-12	Capecitabine for the treatment of gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue Expert Review of Gastroenterology and Hepatology, Vol.9 No.12, pp.1471-1481	DOI
2016-02	Interaction between FOXO1 and human epidermal growth factor receptor 2/neu regulates gastric tumor growth and metastasis 고영산	view file
2016-02	Analysis of gastric microbiota by next generation sequencing 김재연	view file
2016-02	A synergistic interaction between human epidermal growth factor receptor 2/neu and c-Jun N-terminal kinase promotes gastric cancer cell migration and invasion 최이슬	view file
2016-02	Synthesis of targeted ultrasound contrast agent containing chemotherapeutic drug and in vitro evaluation in HER2-positive gastric cancer cell line 이윤진	view file
2016-08	Structural Basis for Differential Transcription Activation by Enantiomeric Agonists of PPARγ and Crystal Structure of TNF-α-Inducing Protein (Tipα) from Helicobacter pylori 장준영	view file
2017-01	Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment An, Eunkyung; Ock, Chan Young; Kim, Tae You; Lee, Kyung Hun; Han, Se Won; Im, Seock Ah; Kim, Tae Yong; Liao, Wei Li; Cecchi, Fabiola; Blackler, Adele; Thyparambil, Sheeno; Kim, W. H.; Burrows, Jon; Hembrough, Todd; Catenacci, Daniel V.T.; Oh, Do Youn; Bang, Yung–Jue Annals of Oncology, Vol.28 No.1, pp.110-115	DOI
2017-02	(The) roles of osteopontin on gastric and hepatic carcinogenesis in mouse model 이수형	view file
2017-02	Tumor heterogeneity in human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer assessed by CT texture analysis: association with survival after trastuzumab treatment Yoon Sung Hyun	view file
2017-02	Long-term effect of Helicobacter pylori eradication on metachronous gastric cancer development 한승준	view file
2017-04	First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors Bang, Y. J.; Giaccone, G.; Im, S. A.; Oh, D. Y.; Bauer, T. M.; Nordstrom, J. L.; Li, H.; Chichili, G. R.; Moore, P. A.; Hong, S.; Stewart, S. J.; Baughman, J. E.; Lechleider, R. J.; Burris, H. A. Annals of Oncology, Vol.28 No.4, pp.855-861	DOI
2017-06	A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification Van Cutsem, E.; Bang, Y. -J.; Mansoor, W.; Petty, R. D.; Chao, Y.; Cunningham, D.; Ferry, D. R.; Smith, N. R.; Frewer, P.; Ratnayake, J.; Stockman, P. K.; Kilgour, E.; Landers, D. Annals of Oncology, Vol.28 No.6, pp.1316-1324	DOI
2017-08	FOXO1 suppression–induced positive crosstalk between HER2 and MET and its effect on acquired lapatinib resistance in HER2-positive gastric cancer cells 박진주	view file
2017-10	Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer Shitara, Kohei; Kim, Tae Min; Yokota, Tomoya; Goto, Masahiro; Satoh, Taroh; Ahn, Jin-Hee; Kim, Hyo Song; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hamauchi, Satoshi; Kudo, Toshihiro; Doi, Toshihido; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79546-79555	DOI
2018-02	Helicobacter pylori is associated with miR-133a expression through promoter methylation in gastric carcinogenesis 임주현	view file
2018-02	Cardia cancer is different from non- cardia cancer in terms of local and systemic immune responses 김형일	view file
2018-02	Epigenetic dysregulations of miR-30a and LINE-1 in gastric cancer 민지민	view file
2018-02	FOXO1 reduces tumorsphere formation capacity via reciprocal down-regulation of LGR5 in gastric cancer cells 최이슬	view file
2018-02	Comprehensive analysis of molecular characteristics and tumor immune microenvironment in stage II and III gastric carcinoma 고지원	view file
2018-02	Development of Lymph Node Metastasis Prediction Model on Each Station in Gastric Cancer Patient 김종원	view file
2018-10	Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: Primary analysis of JAVELIN Gastric 300 Bang, Y. -J.; Ruiz, E. Yanez; Van Cutsem, E.; Lee, K. -W.; Wyrwicz, L.; Schenker, M.; Alsina, M.; Ryu, M. -H.; Chung, H. -C.; Evesque, L.; Al-Batran, S. -E.; Park, S. H.; Lichinitser, M.; Boku, N.; Moehler, M. H.; Hong, J.; Xiong, H.; Hallwachs, R.; Conti, I.; Taieb, J. Annals of Oncology, Vol.29 No.10, pp.2052-2060	DOI
2019-02	Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design Moehler, Markus; Ryu, Min-Hee; Dvorkin, Mikhail; Lee, Keun-Wook; Coskun, Hasan S.; Wong, Rachel; Chung, Hyun C.; Poltoratsky, Artem; Tsuji, Akihito; Yen, Chia Jui; Muntean, Alina S.; Le Sourd, Samuel; Vaccaro, Gina M.; Overton, Lindsay; Boku, Narikazu; Wainberg, Zev A.; Patel, Manish; Sharma, Maitreyi; Xiong, Huiling; Conti, Ilaria; Taieb, Julien; Bang, Yung-Jue Future Oncology, Vol.15 No.6, pp.567-577	DOI
2019-02	SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer van den Boom, Hector G.; Abu-Hanna, Ameen; ter Veer, Emil; van Kleef, Jessy Joy; Lordick, Florian; Stahl, Michael; Ajani, Jaffer A.; Guimbaud, Rosine; Park, Se Hoon; Dutton, Susan J.; Bang, Yung-Jue; Boku, Narikazu; Mohammad, Nadia Haj; Sprangers, Mirjam A. G.; Verhoeven, Rob H. A.; Zwinderman, Aeilko H.; van Oijen, Martijn G. H.; van Laarhoven, Hanneke W. M. Cancers, Vol.11 No.2, p. 187	DOI
2019-03	KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Ohtsu, Atsushi; Tabernero, Josep; Ilson, David H.; Hyung, Woo Jin; Strong, Vivian E.; Goetze, Thorsten Oliver; Yoshikawa, Takaki; Tang, Laura H.; Hwang, Peggy May Tan; Webb, Nancy; Adelberg, David; Shitara, Kohei Future Oncology, Vol.15 No.9, pp.943-952	DOI
2019-05	CRISPR-Cas9 Screening of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells Gruffaz, Marion; Yuan, Hongfeng; Meng, Wen; Liu, Hui; Bae, Sangsu; Kim, Jin-Soo; Lu, Chun; Huang, Yufei; Gao, Shou-Jiang mBio, Vol.10 No.3, p. e00866-19	view file DOI
2019-05	Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer Kim, Hee Sung; Hwang, In Gyu; Min, Hye Young; Bang, Yung-Jue; Kim, Woo Ho Oncology Letters, Vol.17 No.5, pp.4383-4392	DOI
2021	assessment of copy number in proto-oncogenes are predictive of poor survial in advanced gastric cancer 리메이휘	view file link
2021-02	First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811 Chung, Hyun Cheol; Bang, Yung-Jue; S Fuchs, Charles; Qin, Shu-Kui; Satoh, Taroh; Shitara, Kohei; Tabernero, Josep; van Cutsem, Eric; Alsina, Maria; Cao, Zhu Alexander; Lu, Jia; Bhagia, Pooja; Shih, Chie-Schin; Janjigian, Yelena Y. Future Oncology, Vol.17 No.5, pp.491-501	DOI
2021-03	KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma Tabernero, Josep; Bang, Yung-Jue; Van Cutsem, Eric; Fuchs, Charles S.; Janjigian, Yelena Yuriy; Bhagia, Pooja; Li, Kan; Adelberg, David; Qin, Shu Kui Future Oncology, Vol.17 No.22, pp.2847-2855	DOI
2021-08	Quality of life with first-line pembrolizumab for PD-L1epositive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study Van Cutsem, E.; Valderrama, A.; Bang, Y. -J.; Fuchs, C. S.; Shitara, K.; Janjigian, Y. Y.; Qin, S.; Larson, T. G.; Shankaran, V.; Stein, S.; Norquist, J. M.; Kher, U.; Shah, S.; Alsina, M. Esmo Open, Vol.6 No.4, p. 100189	DOI
2021-09	Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma Shitara, K.; Ozguroglu, M.; Bang, Y-J; Di Bartolomeo, M.; Mandala, M.; Ryu, M-H; Caglevic, C.; Chung, H. C.; Muro, K.; Van Cutsem, E.; Kobie, J.; Cristescu, R.; Aurora-Garg, D.; Lu, J.; Shih, C-S; Adelberg, D.; Cao, Z. A.; Fuchs, C. S. Annals of Oncology, Vol.32 No.9, pp.1127-1136	DOI
2023-06	Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: Phase 2 study results Ciardiello, Fortunato; Bang, Yung-Jue; Cervantes, Andres; Dvorkin, Mikhail; Lopez, Charles D.; Metges, Jean-Philippe; Sanchez Ruiz, Antonio; Calvo, Mariona; Strickland, Andrew H.; Kannourakis, George; Muro, Kei; Kawakami, Hisato; Wei, Jia; Borg, Christophe; Zhu, Zhaoyin; Gupta, Neal; Pelham, Robert J.; Shen, Lin Cancer Medicine, Vol.12 No.12, pp.1-10	DOI
2023-10	Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo Kim, Jin-Soo; Kim, Mi Young; Hong, Sungyoul Cancers, Vol.15 No.19, p. 4768	DOI

1 2 3